Search Within

Julia Catherine Wolfe

Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (13)
  2. GSK Faculty (11)
  3. Human Oncology and Pathogenesis Program (11)
  4. Radiology, Department of (7)
  5. Neuroradiology Service (6)
  6. Alumni (GSK) (3)

More Groups

People
  1. Christian Grommes (13)
  2. Lisa De Angelis (12)
  3. Ingo Mellinghoff (11)
  4. Craig Nolan (10)
  5. Elena Pentsova (8)
  6. Thomas Kaley (7)

More People

Years
  1. 2024 (1)
  2. 2021 (1)
  3. 2019 (4)
  4. 2018 (1)
  5. 2017 (2)
  6. 2016 (6)
Publications
  1. Annals of Oncology (2)
  2. Blood (2)
  3. Journal of Clinical Oncology (2)
  4. Neuro-Oncology (2)
  5. Annals of Neurology (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Oxford University Press (4)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. American Society of Hematology (2)
  5. Lippincott Williams & Wilkins (2)
  6. Springer (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-agent ibrutinib in recurrent/refractory central nervous system lymphoma
    Meeting Abstract

    Grommes, C.; Pastore, A.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A. M.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Phase II study of single agent buparlisib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Pentsova, E.; Nolan, C.; Wolfe, J.; Mellinghoff, I.; DeAngelis, L.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II study of single agent Ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I.; DeAngelis, L.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of single agent buparlisib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Pentsova, E.; Nolan, C.; Wolfe, J.; Mellinghoff, I. K.; Deangelis, L.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I. K.; Deangelis, L.
    Annals of Oncology (2016)

    Fulltext@MSK | Save